Company Selected - Takeda Pharmaceutical Co. Ltd. - Income Statement
| Fiscal Year is From April To March - All Figures are in JPY, Thousands, Except for the Diluted EPS Figure | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | View Chart |
|---|---|---|---|---|---|
| 4,417,004,000 | 4,480,246,000 | 4,581,551,000 | 4,579,021,000 | ||
| 1,959,212,000 | 2,115,876,000 | 2,149,348,000 | 2,154,627,000 | ||
| 1,215,870,000 | 1,365,064,000 | 1,387,952,000 | 1,396,256,000 | ||
| 743,342,000 | 750,812,000 | 761,396,000 | 758,371,000 | ||
| 2,457,792,000 | 2,364,370,000 | 2,432,203,000 | 2,424,394,000 | ||
| 2,016,170,000 | 1,796,276,000 | 1,834,993,000 | 1,804,210,000 | ||
| 1,075,890,000 | 1,090,621,000 | 1,104,766,000 | 1,094,134,000 | ||
| 691,573,000 | 705,655,000 | 730,227,000 | 710,076,000 | ||
| 248,707,000 | 0.0 | 0.0 | 0.0 | ||
| 441,622,000 | 568,094,000 | 597,210,000 | 620,184,000 | ||
| -139,344,000 | -164,940,000 | -160,554,000 | -145,837,000 | ||
Hid Interest Expense | 272,216,000 | 257,532,000 | 210,065,000 | 206,928,000 | |
Hid Interest Income | 133,309,000 | 93,029,000 | 49,948,000 | 76,589,000 | |
| 437,000 | 437,000 | 437,000 | 15,498,000 | ||
| -343,710,000 | -378,984,000 | -422,126,000 | -385,323,000 | ||
| 97,912,000 | 189,110,000 | 175,084,000 | 234,861,000 | ||
| 64,625,000 | 51,988,000 | 66,941,000 | 26,614,000 | ||
| 33,075,000 | 136,923,000 | 107,928,000 | 208,065,000 | ||
Hid [-] Net Income | 33,075,000 | 136,923,000 | 107,928,000 | 208,065,000 | |
| 33,287,000 | 137,122,000 | 108,143,000 | 208,247,000 | ||
HidHidHid Net Income From Continuing Ops | 33,287,000 | 137,122,000 | 108,143,000 | 208,247,000 | |
HidHidHid Discontinued Operations | - | - | - | - | |
HidHid Minority Interest Expense | 211,000 | 200,000 | 215,000 | 182,000 | |
| 0.0 | 0.0 | 0.0 | 0.0 | ||
| 19.98 | 84.63 | 66.34 | 129.77 | ||
| 1,577,466 | 1,588,176 | 1,578,460 | 1,631,650 | ||
| 1,136,918,000 | 1,201,266,000 | 1,150,532,000 | 1,199,619,000 | ||
| 373,403,000 | 450,454,000 | 389,136,000 | 441,248,000 |